This single-center retrospective study was designed to evaluate the use of basiliximab as an alternative rescue maintenance immunosuppression in situations where standard maintenance immunosuppression is not tolerated after a pancreas transplant. All pancreas transplants performed between January 11, 2006, and January 6, 2022, were reviewed. All recipients received rabbit antithymocyte globulin (rATG) induction with tacrolimus + sirolimus maintenance for simultaneous pancreas and kidney (SPK) and additional low-dose mycophenolic acid for pancreas transplant alone (PTA).
View Article and Find Full Text PDFCurr Opin Organ Transplant
December 2024
Purpose Of Review: Highlight the importance of acute kidney injury (AKI) among liver transplant candidates, its importance of survival and the vital role of continuous renal replacement therapy (CRRT) as a supportive therapy.
Recent Findings: Kidney dysfunction is common in the preliver transplant patient. Early recognition, broad diagnostic work up, and therapeutic interventions are vital in minimizing morbidity and mortality in this critically ill group of patients.
The goal of this study is to document outcomes of ablation for high-risk accessory pathways in paediatrics using 3D mapping systems with minimal to zero fluoroscopy. It is a cross-sectional, multicentre study, conducted between 2013 and 2023, and involving four different centres in Hungary, Croatia, Kuwait, and Slovenia. A total of 128 procedures were performed on 111 patients.
View Article and Find Full Text PDFThe goal of the present work is to create ZnO/NiO nanocomposites (NCs) for the photocatalytic destruction of organic contaminants using the co-precipitation technique. To investigate physiochemical characteristics, FT-IR, UV visible spectroscopy, SEM, and XRD were used. The ZnO hexagonal phase and the NiO cubic phase in the ZnO/NiO NCs were verified by the diffraction pattern.
View Article and Find Full Text PDFLeishmaniasis is a neglected tropical disease caused by protozoan parasites and transmitted to humans by the sandfly vector. Currently, the disease has limited therapeutic alternatives. Thiourea derivatives were designed, synthesized, and screened for antileishmanial activity.
View Article and Find Full Text PDF